Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Non-Current Debt (2023 - 2025)

Baird Medical Investment Holdings has reported Non-Current Debt over the past 3 years, most recently at $6.1 million for Q4 2025.

  • For Q4 2025, Non-Current Debt rose 76.8% year-over-year to $6.1 million; the TTM value through Dec 2025 reached $6.1 million, up 76.8%, while the annual FY2025 figure was $6.1 million, 76.8% up from the prior year.
  • Non-Current Debt for Q4 2025 was $6.1 million at Baird Medical Investment Holdings, up from $5.8 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $6.1 million in Q4 2025 and troughed at $1.6 million in Q4 2023.
  • A 3-year average of $4.2 million and a median of $4.6 million in 2024 define the central range for Non-Current Debt.
  • Biggest five-year swings in Non-Current Debt: skyrocketed 113.35% in 2024 and later surged 76.8% in 2025.
  • Year by year, Non-Current Debt stood at $1.6 million in 2023, then surged by 113.35% to $3.4 million in 2024, then surged by 76.8% to $6.1 million in 2025.
  • Business Quant data shows Non-Current Debt for BDMD at $6.1 million in Q4 2025, $5.8 million in Q2 2025, and $3.4 million in Q4 2024.